International Association for the Study of Pain | IASP SIG on Cancer Pain

Animal Models of Mechanisms in Cancer Pain: How do These Differ from Non-cancer Models – Marie Fallon (UK)
Bone and neuropathic pain: Mechanisms and implications for the clinician – Patrick Mantyh (USA)
A classification system for cancer pain: are neuropathic mechanisms important? – Anne-Kari Knudsen (Norway)
How is cancer neuropathic pain currently assessed in clinical studies? Comparisons with IASP criteria – Mike Bennett (UK)
New approaches to clinical assessment: what is the data from screening tools and Quantitative Sensory Testing in neuropathic cancer pain? – Roman Rolke (Germany)
Preventing and treating Chemotherapy-Induced Peripheral Neuropathic pain – Charles Loprinzi (USA)
Initial management of neuropathic cancer pain: opioids and adjuvants – Augusto Caraceni (Italy)
Managing difficult neuropathic cancer pain: what new pharmacological approaches exist? – Eija Kalso (Finland)
Global Efforts in the Relief of Cancer Pain – Kathy Foley (USA)
Neuropathic pain in patients with cancer: Future research questions – Stein Kaasa (Norway)

* These items are accessible by IASP members only.